Most people with the rare blood disorder immune-mediated thrombotic thrombocytopenic purpura (iTTP) recover well after admission to the intensive care unit (ICU), and treatment with…
A woman with the rare blood disorder congenital thrombotic thrombocytopenic purpura (TTP) safely underwent hip replacement surgery while being treated with Adzynma (ADAMTS13…
Seragene Therapeutics has received funding from Pathway to Cures, the venture philanthropy fund of the National Bleeding Disorders Foundation (NBDF), to advance the…
A 36-year-old woman in China with congenital thrombotic thrombocytopenic purpura (TTP) successfully delivered a healthy baby after preventive plasma therapy was started early in pregnancy,…
Applications are now open for the 2026 Eric Dostie Memorial College Scholarships, which will award $1,000 each to 10 qualifying students whose lives have…
Hormonal therapy may not be as effective as previously believed to control heavy menstrual bleeding in women with type 1 von Willebrand disease (VWD),…
Children and adolescents newly diagnosed with immune thrombocytopenia (ITP) show clear differences in gut microbiota — the community of bacteria and other microbes living…
